China’s CanSino in Talks for COVID-19 Vaccine Phase III Trial Overseas

Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday.
( read original story …)